Ischemic Priapism Management

Diagnosis and Treatment

The American Urological Association recommends that all patients presenting with prolonged erection must be evaluated emergently to differentiate between ischemic and non-ischemic subtypes, as management differs completely 2, 5.
Ischemic priapism is a urologic emergency requiring immediate intracavernosal treatment to prevent irreversible erectile dysfunction, with a success rate of 43-81% when combined with aspiration 3.
The use of intracavernosal phenylephrine is superior to other agents due to demonstrated efficacy and limited systemic side effects, with a standard concentration of 100-500 mcg/mL and a maximum dose of 1000 mcg within the first hour 3.
Surgical shunting is indicated when medical management fails after repeated attempts, with distal shunts (Winter, Ebbehoj, T-shunt) having a success rate of 60-80% and proximal shunts (Quackels, Grayhack) having a higher risk of erectile dysfunction 3, 6.

The risk of permanent erectile dysfunction increases significantly after 24 hours of ischemia, and approaches 90% after 48 hours, emphasizing the need for prompt treatment 1.
Early intervention with intracavernosal phenylephrine and aspiration can reduce the risk of erectile dysfunction, with a success rate of 24-36% with aspiration/irrigation alone 3.

Patients with sickle cell disease presenting with ischemic priapism should receive immediate urologic intracavernosal treatment, with concurrent systemic sickle cell interventions, as systemic treatments alone resolved priapism in only 0-37% of sickle cell patients 2, 3, 5, 6.
The use of preventive pharmacotherapy, such as PDE5 inhibitors and hormonal therapy, can reduce the frequency of recurrent ischemic priapism episodes 2, 6.

Cavernosal blood gas analysis is the gold standard for differentiating priapism types, with ischemic priapism blood gas showing pO2 <30 mmHg, pCO2 >60 mmHg, and pH <7.25 1, 4, 6.
Color Doppler ultrasound can also be used to differentiate between ischemic and non-ischemic priapism, with ischemic priapism showing minimal to absent cavernosal arterial flow 1, 6, 7.